ICD-10 Code H32: Chorioretinal disorders in diseases classified elsewhere

Key Takeaways

ICD-10 Code H32 is a billable diagnosis code for chorioretinal disorders caused by an underlying systemic disease classified elsewhere

H32 is a manifestation code: the underlying disease (such as histoplasmosis B39.-, congenital toxoplasmosis P37.1, or leprosy A30.-) must always be sequenced first

Excludes1 notes mean H32 cannot be reported alongside B58.01 (acquired toxoplasmosis chorioretinitis) or A18.53 (tuberculous chorioretinitis)

Pabau’s claims management software helps ophthalmology practices enforce Code First sequencing rules and reduce denials from incorrect diagnosis ordering

ICD-10 Code H32 is the manifestation code ophthalmology and coding teams use when a systemic disease produces chorioretinal complications. This guide covers Code First sequencing, the Excludes1 conflicts that trip up claims, documentation requirements, and billing guidance for submitting clean H32 claims.

ICD-10 Code H32: Definition and clinical description

Ophthalmology practices and coding teams run into ICD-10 Code H32 whenever a systemic disease produces chorioretinal complications. The code is billable, current for 2026, and classified under CMS ICD-10-CM block H30-H36 (Disorders of choroid and retina) as defined by the World Health Organization.

The full official description is: Chorioretinal disorders in diseases classified elsewhere. That phrase tells coders the most important thing about H32 before they touch a chart: the chorioretinal pathology exists because of a disease that is coded somewhere else in the ICD-10-CM tabular list. H32 is a manifestation code. It never stands alone.

The choroid is the vascular layer sitting between the retina and the sclera. The retina converts light into neural signals. When a systemic infection, inflammatory disease, or parasitic condition reaches the eye and disrupts either structure, the resulting chorioretinal disorder is documented with ICD-10 Code H32 after the causative disease code.

Eyelid conditions fall under a different part of the same chapter and should not be confused with chorioretinal disorders. H02.79 covers degenerative eyelid disorders, a separate anatomical structure from the choroid and retina that H32 describes.

Code classification and hierarchy

H32 sits within the eye and adnexa chapter (H00-H59) of CDC/NCHS ICD-10-CM classification. Its immediate neighbours in the H30-H36 block are worth knowing for accurate differential coding:

• H30 – Chorioretinal inflammation (primary inflammatory conditions)
• H31 – Other disorders of choroid
• H32 – Chorioretinal disorders in diseases classified elsewhere (manifestation code)
• H33 – Retinal detachments and breaks
• H34 – Retinal vascular occlusions
• H35 – Other retinal disorders
• H36 – Retinal disorders in diseases classified elsewhere

H32 and H36 are both manifestation codes in the H30-H36 block, which is a common source of confusion. H32 captures disorders affecting the choroid and retina together. H36 is reserved for retinal-only disorders arising from underlying systemic disease, but an Excludes1 note means H36 can never be reported for diabetic retinopathy or hypertensive retinopathy.

Diabetic retinopathy is coded entirely within the diabetes combination codes (E08.3-/E09.3-/E10.3-/E11.3-/E13.3-), the same combination-code pattern seen in E11.9, and hypertensive retinopathy is coded H35.03. H36’s actual Code First examples cover conditions such as sickle-cell disorders (D57.-) and lipid storage disorders (E75.-). If the disorder involves the choroid alongside the retina and stems from infections like histoplasmosis or leprosy, H32 is the correct code.

Underlying diseases and code first sequencing

The Code First instruction is non-negotiable for ICD-10 Code H32. Sequencing the manifestation before the etiology violates the etiology-manifestation convention and will trigger claim edits or denials from Medicare and most commercial payers.

The ICD-10-CM tabular list specifies three disease categories as Code First examples, though the instruction applies to any underlying systemic condition that produces chorioretinal pathology:

The etiology-manifestation convention means these two codes travel as a pair. The underlying disease explains why the chorioretinal disorder exists. H32 describes the eye manifestation. Neither code communicates the full clinical picture without the other, which is why the CDC/NCHS ICD-10-CM coding tool flags manifestation codes with a “Code First” instruction visible in the tabular display.

How EHR and practice management systems handle Code First pairing

Most modern EHR systems allow coders to sequence diagnosis codes manually. The risk is that when a physician documents the eye finding first in the encounter note, billing staff may inadvertently submit H32 as the principal diagnosis.

Practices using claims management software that validates diagnosis ordering before submission catch these sequencing errors before they reach the payer. A claim submitted with H32 in the first position will either edit out or deny at adjudication with most payers, since the code’s own tabular instructions mandate that the underlying disease precede it.

ICD-10 Code H32: Excludes1 notes and adjacent codes

The Excludes1 note for ICD-10 Code H32 lists two specific chorioretinitis conditions that must never be reported alongside H32. An Excludes1 note means the two codes are mutually exclusive: by definition, they cannot coexist in the same encounter.

• B58.01 – Toxoplasma chorioretinitis (acquired toxoplasmosis): this code is used when the patient acquired toxoplasmosis after birth. H32 with underlying P37.1 is for the congenital presentation only.
• A18.53 – Tuberculous chorioretinitis: when tuberculosis is the underlying cause of chorioretinal inflammation, A18.53 is the correct code. Do not use H32 with A30.- thinking this covers tuberculosis-related eye disease.

The clinical reasoning behind these exclusions is precise. Acquired toxoplasmosis and tuberculosis each have their own dedicated ICD-10-CM codes that already capture both the systemic infection and the ocular manifestation in a single code. Using H32 alongside these would constitute double-coding of the same clinical event, which the Excludes1 framework is designed to prevent.

H32 vs. H36: Choosing the right manifestation code

H32 and H36 are the two manifestation codes in the H30-H36 block, and they confuse even experienced coders. The distinction comes down to anatomy and etiology:

• H32 applies to chorioretinal disorders (choroid plus retina) from infectious or inflammatory systemic diseases such as histoplasmosis, congenital toxoplasmosis, and leprosy.
• H36 applies to retinal disorders (retina only) in systemic diseases such as sickle-cell disorders (D57.-) and lipid storage disorders (E75.-). An Excludes1 note bars H36 from ever being used for diabetic retinopathy or hypertensive retinopathy. Billable H36 subcodes are H36.8, H36.81, H36.82, and H36.89.

If your patient has diabetic macular edema or diabetic retinopathy, code entirely within the diabetes combination codes, such as E11.3-. These conditions never pair with an H36 code. If your patient has chorioretinitis secondary to histoplasmosis, code B39.- followed by H32. The anatomy and etiology documented in the encounter note determine which block applies.

The manifestation-code convention is not unique to ophthalmology. F54 and N37 follow the identical etiology-first logic in the behavioral health and genitourinary chapters, respectively.

Documentation requirements for ophthalmology practices

Claim audits and medical necessity reviews for H32 focus almost entirely on documentation quality. Payers want evidence that the underlying disease was confirmed and that the chorioretinal disorder is clinically linked to it, not coincidental.

Four documentation elements reduce audit risk for H32 encounters:

1. Confirmed underlying diagnosis. The systemic disease must appear in the patient’s problem list or be confirmed in the encounter note. A working diagnosis of “possible histoplasmosis” is insufficient to support H32 as a secondary manifestation code. The etiology must be established, not suspected.
2. Explicit causal link. The physician’s note should state that the chorioretinal findings are secondary to the underlying condition (for example, “chorioretinal scarring consistent with histoplasmosis retinitis”). Documenting two separate conditions without connecting them gives coders no basis for H32 over H30 or another primary code.
3. Laterality detail. While H32 itself does not carry laterality subcodes, many of the adjacent codes (H30, H33, H35) do. Document which eye or eyes are affected so that any additional codes submitted alongside H32 reflect the correct laterality.
4. Severity and progression. For recurring encounters, document whether the chorioretinal condition is active, inactive, or improving. This supports medical necessity for ongoing ophthalmology monitoring visits.

Practices managing patient records with structured digital forms can build ophthalmology-specific intake and encounter templates, such as a diabetes eye exam template, that prompt providers to capture causal linkage language and laterality at the point of care, before notes reach the billing queue. This prevents the most common H32 documentation issues before they become claim problems.

Practices with compliance obligations around coding accuracy and audit readiness will find that maintaining structured patient record management reduces the time spent reconstructing documentation when payers request medical records. Meeting HIPAA compliance standards also requires that these records be stored and retrievable in a timely, organized format.

Reduce coding errors before they hit the payer

Pabau's claims management tools help ophthalmology and specialty practices validate diagnosis sequencing, catch Excludes1 conflicts, and submit cleaner claims. See how it works.

Book a demo

Billing and reimbursement considerations

H32 is a valid billable code for reimbursement purposes. It can support claims for evaluation and management visits such as 92002, diagnostic imaging such as fundus photography (92250) or fluorescein angiography, and follow-up encounters in ophthalmology and optometry settings.

The code does not in itself restrict coverage, but the payer’s policy on the underlying condition and on eye disease monitoring will determine whether the encounter is reimbursable.

A few billing realities practices should factor into their H32 claims workflow:

• Pair the code correctly or expect edits. Submitting H32 without the causative etiology code in position 1 will commonly generate a coding edit. The ICD-10-CM sequencing convention is recognized by most clearinghouses and payer edit engines.
• Payer coverage varies for the underlying disease. Whether an ophthalmology visit for histoplasmosis-related chorioretinitis is covered depends substantially on the patient’s plan and the payer’s coverage policy for B39.-. Check the local coverage determination (LCD) for the ophthalmology procedure codes billed on the same claim.
• Avoid upcoding with H30. H30 (Chorioretinal inflammation) requires that the inflammation be primary, meaning it is the condition itself rather than a manifestation of something else. Coding H30 when H32 is the correct manifestation code misrepresents the clinical picture and may trigger a fraud and abuse review if identified during a payer audit.

The AAPC Codify ICD-10-CM lookup provides crosswalk data that can help coders confirm which procedure codes are commonly reported alongside H32 and the appropriate underlying disease codes.

Practices reviewing other manifestation-code patterns for systemic diseases may also find it useful to see how D77 sequencing works, since the same etiology-first convention governs both code sets.

Modifiers and bundling considerations

H32 itself does not carry procedure-level modifiers. Modifiers attach to the CPT procedure codes billed on the claim, not to the ICD-10 diagnosis code. However, laterality modifiers on the procedure side (RT/LT or -E1 through -E4 for eyelid procedures) should reflect the affected eye documented in the encounter note.

If bilateral chorioretinal involvement is documented, both eyes should be reflected in procedure code modifiers where applicable. Coders managing multi-payer ophthalmology billing will find that supporting specialty compliance requirements through systematic documentation templates reduces modifier-related rejections.

Practices using automated workflows can link procedure codes to diagnosis codes in their billing module to reduce manual pairing errors. The automated workflows in practice management platforms that enforce coding rules at the time of claim creation consistently outperform manual review in preventing sequencing and pairing errors at scale.

Conclusion

ICD-10 Code H32 is straightforward once coders understand its role as a manifestation code. The underlying disease always comes first. Excludes1 conditions (acquired toxoplasmosis B58.01, tuberculous chorioretinitis A18.53) never pair with it. Documentation must establish both the systemic etiology and its causal link to the chorioretinal finding.

For ophthalmology practices processing high volumes of manifestation code claims, having a practice management system that validates diagnosis order before submission removes the most common failure point. Pabau’s compliance management tools and claims workflow help specialty practices maintain coding accuracy across complex multi-code encounters. To see how it handles H32 and other manifestation code workflows, book a demo.

Continue your research

Need a reference for other systemic disease manifestation codes? I61 covers etiology-manifestation sequencing for neurological diagnoses.

Managing coding accuracy across a multi-specialty practice? Pabau’s automated workflows enforce diagnosis sequencing rules automatically before claims reach the payer.

Want to reduce audit risk with better documentation workflows? patient data security tools outlines how structured record-keeping supports audit readiness.

Frequently asked questions